Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) Form 13F Holdings: Other

BRISTOL-MYERS SQUIBB COMPANY : Form 13F Holdings

Positions as retained from the SEC Form 13F data sets, by quarter and CUSIP. Class, amount and value are as filed.

  • 2026-06-30: CUSIP 110122140; Class as filed RIGHT 12/30/2030; Managers 15; Principal or shares as filed 296,494.
  • 2026-03-31: CUSIP 110122140; Class as filed RIGHT 12/30/2030; Managers 17; Principal or shares as filed 328,558.
  • 2025-12-31: CUSIP 110122140; Class as filed RIGHT 12/30/2030; Managers 18; Principal or shares as filed 353,781.
  • 2025-12-31: CUSIP 110122157; Class as filed RTS; Managers 1; Principal or shares as filed 505,289.
Quarter endCUSIPClass as filedManagersPrincipal or shares as filedValue (USD)
2026-06-30110122140RIGHT 12/30/203015296,494$26,485.00
2026-03-31110122140RIGHT 12/30/203017328,558$37,862.00
2025-12-31110122140RIGHT 12/30/203018353,781$24,060.00
2025-12-31110122157RTS1505,289$0.00
2025-09-30110122140RIGHT 12/30/2030221,221,946$1,224,443.00
2025-09-30110122157RTS1522,789$0.00
2025-06-30110122140RIGHT 12/30/203023485,584$57,208.00
2025-06-30110122157RTS1522,789$0.00
2025-03-31110122140RIGHT 12/30/203021473,348$66,979.00
2025-03-31110122157RTS1552,539$0.00
2024-12-31110122140RIGHT 12/30/203021934,134$6,420,477.00
2024-12-31110122157RTS1553,789$0.00
2024-09-30110122140RIGHT 12/30/203022592,069$5,197,536.00
2024-09-30110122157RTS1553,789$0.00
2024-06-30110122140RIGHT 12/30/203019502,206$4,169,389.00
2024-06-30110122157RTS1553,789$0.00
2024-03-31110122140RIGHT 12/30/203020488,451$5,444,229.00
2024-03-31110122157RTS1560,789$0.00
2023-12-31110122140RIGHT 12/30/203018494,369$5,166,270.00
2023-12-31110122157RTS1560,789$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64